Merger of Fujirebio Europe NV and ADx NeuroSciences NV

Following the acquisition of ADx NeuroSciences NV by Fujirebio Europe NV in 2022 (read the press release here), the merger will officially take effect on 1 April 2026.

 
What does this mean for ADx NeuroSciences NV customers?

  • All operations will be conducted under the name Fujirebio Europe NV.

  • Our commitment to delivering high-quality service remains unchanged. The integration of our teams enables us to offer you an expanded portfolio and a broader range of expertise.

  • You will continue to have access to all familiar services and information via the Fujirebio website. For now, we invite you to visit: www.adxneurosciences.com. 

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.